Stay updated on SafetyEfficacyLDXADHDAdultsClinicalTrial
Sign up to get notified when there's something new on the SafetyEfficacyLDXADHDAdultsClinicalTrial page.

Latest updates to the SafetyEfficacyLDXADHDAdultsClinicalTrial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been changed from June 2025 to July 2025.SummaryDifference0.8%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check33 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check77 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a detailed study on Lisdexamfetamine Dimesylate (LDX) for ADHD, including inclusion and exclusion criteria, which may impact the understanding of the study's scope and methodology.SummaryDifference18%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to SafetyEfficacyLDXADHDAdultsClinicalTrial
Enter your email address, and we'll notify you when there's something new on the SafetyEfficacyLDXADHDAdultsClinicalTrial page.